![Jay Stout](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Stout
Teknisk/Vetenskaplig/F&U Direktör på
IMMUNOVANT, INC.
Förmögenhet: 7 M $ per 2026-09-30
Profil
Jay S.
Stout is currently Chief Technology Officer at Immunovant, Inc. since 2023.
Formerly, Dr. Stout was Chief Technical Officer at Immunomedics, Inc. and Senior Vice President-Technical Operations at Versartis, Inc. Education includes undergraduate and graduate degrees from the University of Iowa and a doctorate from The University of Nebraska-Lincoln.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IMMUNOVANT INC 0,1 % | 2026-07-23 | 205 341 ( 0,1 % ) | 7 M $ | 2026-09-30 |
Aktiva positioner av Jay Stout
| Företag | Position | Start |
|---|---|---|
| IMMUNOVANT, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-04-01 |
Tidigare kända positioner av Jay Stout
| Företag | Position | Slut |
|---|---|---|
| IMMUNOMEDICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Teknisk/Vetenskaplig/F&U Direktör | - |
Jay Stouts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
37
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
The University of Nebraska-Lincoln
 The University of Nebraska-Lincoln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
